Stock Earnings

Question 1

What are Alvotech's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Medigene AG has a total asset of $31, Net loss of $-16

Question 2

What are the key financial ratios for ALVOW?

Accepted Answer

Medigene AG's Current ratio is 3.1, has a Net margin is -266.66, sales per share of $0.46.

Question 3

How is Alvotech's revenue broken down by segment or geography?

Accepted Answer

Medigene AG largest revenue segment is Immunotherapies, at a revenue of 6,034,000 in the most earnings release.For geography, Germany is the primary market for Medigene AG, at a revenue of 6,034,000.

Question 4

Is Alvotech profitable?

Accepted Answer

no, according to the latest financial statements, Medigene AG has a net loss of $-16

Question 5

Does Alvotech have any liabilities?

Accepted Answer

yes, Medigene AG has liability of 10

Question 6

How many outstanding shares for Alvotech?

Accepted Answer

Medigene AG has a total outstanding shares of 12.93

Breakdown	TTM	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Revenue	4	6	31	10	8	10
Revenue Growth (YoY)	33%	-81%	210%	25%	-20%	43%
Cost of Revenue	0	1	1	1	1	0
Gross Profit	1	4	29	9	7	10
Selling, General & Admin	2	9	9	6	8	7
Research & Development	6	10	6	9	18	20
Operating Expenses	8	20	37	19	36	30
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-4	-16	-9	-10	-28	-19
Income Tax Expense	0	0	-1	0	0	0
Net Income	-4	-16	-8	-9	-28	-19
Net Income Growth	-33%	100%	-11%	-68%	47%	-10%
Shares Outstanding (Diluted)	13.59	12.93	12.93	12.93	24.56	24.56
Shares Change (YoY)	-47%	0%	0%	-47%	0%	4%
EPS (Diluted)	-0.3	-1.25	-0.64	-0.77	-1.17	-0.81
EPS Growth	11%	94%	-17%	-34%	45%	-9%
Free Cash Flow	-22	-15	10	-10	-25	-17
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	25%	66.66%	93.54%	90%	87.5%	100%
Operating Margin	-100%	-266.66%	-25.8%	-90%	-350%	-200%
Profit Margin	-100%	-266.66%	-25.8%	-90%	-350%	-190%
Free Cash Flow Margin	-550%	-250%	32.25%	-100%	-312.5%	-170%
EBITDA	-3	-15	13	-6	-22	-18
EBITDA Margin	-75%	-250%	41.93%	-60%	-275%	-180%
D&A For EBITDA	1	1	21	3	6	2
EBIT	-4	-16	-8	-9	-28	-20
EBIT Margin	-100%	-266.66%	-25.8%	-90%	-350%	-200%
Effective Tax Rate	0%	0%	11.11%	0%	0%	0%

Alvotech (ALVOW) Financial

ALVOW Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

ALVOW Income

Follow-Up Questions